{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:17:59Z","timestamp":1793650679212,"version":"4.5.1"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T00:00:00Z","timestamp":1530835200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Gobierno Vasco-Eusko Jaurlaritza","award":["GIC15 78 IT-990-16"],"award-info":[{"award-number":["GIC15 78 IT-990-16"]}]},{"name":"Ministerio de Econom\u00eda y Competitividad del Gobierno de Espa\u00f1a","award":["SAF2017-86188-P"],"award-info":[{"award-number":["SAF2017-86188-P"]}]},{"DOI":"10.13039\/501100003451","name":"Universidad del Pa\u00eds Vasco","doi-asserted-by":"crossref","award":["UFI 11\/25"],"award-info":[{"award-number":["UFI 11\/25"]}],"id":[{"id":"10.13039\/501100003451","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Microbiol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s10123-018-0014-1","type":"journal-article","created":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T09:15:51Z","timestamp":1530868551000},"page":"107-119","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":102,"title":["The continuous changes in the aetiology and epidemiology of invasive candidiasis: from familiar Candida albicans to multiresistant Candida auris"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0438-2248","authenticated-orcid":false,"given":"Guillermo","family":"Quind\u00f3s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Marcos-Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"San-Mill\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estibaliz","family":"Mateo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Eraso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,6]]},"reference":[{"key":"14_CR1","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1128\/JCM.01811-10","volume":"49","author":"MC Arendrup","year":"2011","unstructured":"Arendrup MC, Bruun B, Christensen JJ, Fuursted K, Johansen HK, Kjaeldgaard P, Knudsen JD, Kristensen L, M\u00f8ller J, Nielsen L, Rosenvinge FS, R\u00f8der B, Sch\u00f8nheyder HC, Thomsen MK, Truberg K (2011) National surveillance of fungemia in Denmark (2004 to 2009). J Clin Microbiol 49:325\u2013334","journal-title":"J Clin Microbiol"},{"key":"14_CR2","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1128\/JCM.02566-12","volume":"51","author":"LR Asmundsdottir","year":"2013","unstructured":"Asmundsdottir LR, Erlendsdottir H, Gottfredsson M (2013) Nationwide study of candidemia, antifungal use and antifungal drug resistance in Iceland, 2000-2011. J Clin Microbiol 51:841\u2013848","journal-title":"J Clin Microbiol"},{"key":"14_CR3","first-page":"e01564","volume":"56","author":"KMT Astvad","year":"2018","unstructured":"Astvad KMT, Johansen HK, R\u00f8der BL, Rosenvinge FS, Knudsen JD, Lemming L, Sch\u00f8nheyder HC, Hare RK, Kristensen L, Nielsen L, Gertsen JB, Dzajic E, Pedersen M, \u00d8sterg\u00e5rd C, Olesen B, S\u00f8ndergaard TS, Arendrup MC (2018) Update from a twelve-year nationwide fungaemia surveillance: increasing intrinsic and acquired resistance causes concern. J Clin Microbiol 56:e01564\u2013e01517","journal-title":"J Clin Microbiol"},{"key":"14_CR4","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/myc.12013","volume":"56","author":"MD Bergamasco","year":"2013","unstructured":"Bergamasco MD, Garnica M, Colombo AL, Nucci M (2013) Epidemiology of candidemia in patients with hematologic malignancies and solid tumours in Brazil. Mycoses 56:256\u2013263","journal-title":"Mycoses"},{"key":"14_CR5","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3201\/eid2007.140087","volume":"20","author":"D Bitar","year":"2014","unstructured":"Bitar D, Lortholary O, Le Strat Y, Nicolau J, Coignard B, Tattevin P, Che D, Dromer F (2014) Population-based analysis of invasive fungal infections, France, 2001-2010. Emerg Infect Dis 20:1149\u20131155","journal-title":"Emerg Infect Dis"},{"key":"14_CR6","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/mmy\/myw147","volume":"55","author":"AM Borman","year":"2017","unstructured":"Borman AM, Szekely A, Johnson EM (2017) Isolates of the emerging pathogen Candida auris present in the UK have several geographic origins. Med Mycol 55:563\u2013567","journal-title":"Med Mycol"},{"key":"14_CR7","doi-asserted-by":"crossref","unstructured":"Calvo B, Melo AS, Perozo-Mena A, Hernandez M, Francisco EC, Hagen F, Meis JF, Colombo AL (2016) First report of Candida auris in America: clinical and microbiological aspects of 18 episodes of candidemia. J Infect 73:369\u2013374","DOI":"10.1016\/j.jinf.2016.07.008"},{"key":"14_CR8","doi-asserted-by":"crossref","unstructured":"Cant\u00f3n E, Pem\u00e1n J, Quind\u00f3s G, Eraso E, Miranda-Zapico I, \u00c1lvarez M, Merino P, Campos-Herrero I, Marco F, de la Pedrosa EG, Yag\u00fce G, Guna R, Rubio C, Miranda C, Pazos C, Velasco D, FUNGEMYCA Study Group (2011) Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis isolated from patients with candidemia. Antimicrob Agents Chemother 55:5590\u20135596","DOI":"10.1128\/AAC.00466-11"},{"key":"14_CR9","doi-asserted-by":"publisher","first-page":"e01907","DOI":"10.1128\/JCM.01907-17","volume":"56","author":"M Castanheira","year":"2018","unstructured":"Castanheira M (2018) Fungemia surveillance in Denmark demonstrates emergence of non-albicans Candida species and higher antifungal usage and resistance rates than in other nations. J Clin Microbiol 56:e01907\u2013e01917","journal-title":"J Clin Microbiol"},{"key":"14_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00134-014-3603-2","volume":"41","author":"A Chakrabarti","year":"2015","unstructured":"Chakrabarti A, Sood P, Rudramurthy SM, Chen S, Kaur H, Capoor M, Chhina D, Rao R, Eshwara VK, Xess I, Kindo AJ, Umabala P, Savio J, Patel A, Ray U, Mohan S, Iyer R, Chander J, Arora A, Sardana R, Roy I, Appalaraju B, Sharma A, Shetty A, Khanna N, Marak R, Biswas S, Das S, Harish BN, Joshi S, Mendiratta D (2015) Incidence, characteristics and outcome of ICU-acquired candidemia in India. Intensive Care Med 41:285\u2013295","journal-title":"Intensive Care Med"},{"key":"14_CR11","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1093\/jac\/dkx047","volume":"72","author":"B Chapman","year":"2017","unstructured":"Chapman B, Slavin M, Marriott D, Halliday C, Kidd S, Arthur I, Bak N, Heath CH, Kennedy K, Morrissey CO, Sorrell TC, van Hal S, Keighley C, Goeman E, Underwood N, Hajkowicz K, Hofmeyr A, Leung M, Macesic N, Botes J, Blyth C, Cooley L, George CR, Kalukottege P, Kesson A, McMullan B, Baird R, Robson J, Korman TM, Pendle S, Weeks K, Liu E, Cheong E, Chen S, Australian and New Zealand Mycoses Interest Group (2017) Changing epidemiology of candidaemia in Australia. J Antimicrob Chemother 72:1103\u20131108 Erratum in: (2017) J Antimicrob Chemother 72:1270","journal-title":"J Antimicrob Chemother"},{"key":"14_CR12","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.3201\/eid1210.060389","volume":"12","author":"S Chen","year":"2006","unstructured":"Chen S, Slavin M, Nguyen Q, Marriott D, Playford EG, Ellis D, Sorrell T, Australian Candidemia Study (2006) Active surveillance for candidemia, Australia. Emerg Infect Dis 12:1508\u20131516","journal-title":"Emerg Infect Dis"},{"key":"14_CR13","doi-asserted-by":"publisher","first-page":"e1006290","DOI":"10.1371\/journal.ppat.1006290","volume":"13","author":"A Chowdhary","year":"2017","unstructured":"Chowdhary A, Sharma C, Meis JF (2017) Candida auris: a rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally. PLoS Pathog 13:e1006290","journal-title":"PLoS Pathog"},{"key":"14_CR14","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/jac\/dkx480","volume":"73","author":"A Chowdhary","year":"2018","unstructured":"Chowdhary A, Prakash A, Sharma C, Kordalewska M, Kumar A, Sarma S, Tarai B, Singh A, Upadhyaya G, Upadhyay S, Yadav P, Singh PK, Khillan V, Sachdeva N, Perlin DS, Meis JF (2018) A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance. J Antimicrob Chemother 73:891\u2013899","journal-title":"J Antimicrob Chemother"},{"key":"14_CR15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/cid\/ciw696","volume":"64","author":"CJ Clancy","year":"2017","unstructured":"Clancy CJ, Nguyen MH (2017) Emergence of Candida auris: an international call to arms. Clin Infect Dis 64:141\u2013143","journal-title":"Clin Infect Dis"},{"key":"14_CR16","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/cid\/cis697","volume":"55","author":"AA Cleveland","year":"2012","unstructured":"Cleveland AA, Farley MM, Harrison LH, Stein B, Hollick R, Lockhart SR, Magill SS, Derado G, Park BJ, Chiller TM (2012) Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008\u20132011. Clin Infect Dis 55:1352\u20131356","journal-title":"Clin Infect Dis"},{"key":"14_CR17","doi-asserted-by":"publisher","first-page":"e0120452","DOI":"10.1371\/journal.pone.0120452","volume":"10","author":"AA Cleveland","year":"2015","unstructured":"Cleveland AA, Harrison LH, Farley MM, Hollick R, Stein B, Chiller TM, Lockhart SR, Park BJ (2015) Declining incidence of candidemia and the shifting epidemiology of Candida resistance in two US metropolitan areas, 2008-2013: results from population-based surveillance. PLoS One 10:e0120452","journal-title":"PLoS One"},{"key":"14_CR18","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1128\/JCM.00773-06","volume":"44","author":"AL Colombo","year":"2006","unstructured":"Colombo AL, Nucci M, Park BJ, Nou\u00e9r SA, Arthington-Skaggs B, da Matta DA, Warnock D, Morgan J, Brazilian Network Candidemia Study (2006) Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol 44:2816\u20132823","journal-title":"J Clin Microbiol"},{"key":"14_CR19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3109\/13693786.2012.698024","volume":"51","author":"AL Colombo","year":"2013","unstructured":"Colombo AL, Garnica M, Aranha Camargo LF, Da Cunha CA, Bandeira AC, Borghi D, Campos T, Senna AL, Valias Didier ME, Dias VC, Nucci M (2013) Candida glabrata: an emerging pathogen in Brazilian tertiary care hospitals. Med Mycol 51:38\u201344","journal-title":"Med Mycol"},{"key":"14_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1099\/ijs.0.64076-0","volume":"56","author":"A Correia","year":"2006","unstructured":"Correia A, Sampaio P, James S, Pais C (2006) Candida bracarensis sp. nov., a novel anamorphic yeast species phenotypically similar to Candida glabrata. Int J Syst Evol Microbiol 56:313\u2013317","journal-title":"Int J Syst Evol Microbiol"},{"key":"14_CR21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.riam.2010.12.002","volume":"28","author":"JA Cort\u00e9s","year":"2011","unstructured":"Cort\u00e9s JA, Reyes P, G\u00f3mez C, Buitrago G, Leal AL, GREBO Group (2011) Fungal bloodstream infections in tertiary care hospitals in Colombia. Rev Iberoam Micol 28:74\u201378","journal-title":"Rev Iberoam Micol"},{"key":"14_CR22","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.bjid.2014.06.009","volume":"18","author":"JA Cort\u00e9s","year":"2014","unstructured":"Cort\u00e9s JA, Reyes P, Gomez CH, Cuervo SI, Rivas P, Casas CA, S\u00e1nchez R (2014) Clinical and epidemiological characteristics and risk factors for mortality in patients with candidemia in hospitals from Bogota, Colombia. Braz J Infect Dis 18:631\u2013637","journal-title":"Braz J Infect Dis"},{"key":"14_CR23","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.micpath.2018.02.028","volume":"117","author":"M Dadar","year":"2018","unstructured":"Dadar M, Tiwari R, Karthik K, Chakraborty S, Shahali Y, Dhama K (2018) Candida albicans - biology, molecular characterization, pathogenicity, and advances in diagnosis and control\u2014an update. Microb Pathog 117:128\u2013138","journal-title":"Microb Pathog"},{"key":"14_CR24","doi-asserted-by":"publisher","first-page":"e0146909","DOI":"10.1371\/journal.pone.0146909","volume":"11","author":"AM Doi","year":"2016","unstructured":"Doi AM, Pignatari AC, Edmond MB, Marra AR, Camargo LF, Siqueira RA, da Mota VP, Colombo AL (2016) Epidemiology and microbiologic characterization of nosocomial candidemia from a Brazilian National Surveillance Program. PLoS One 11:e0146909","journal-title":"PLoS One"},{"key":"14_CR25","unstructured":"ECDC (2016) Candida auris in healthcare settings \u2013 Europe. \n                    http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/Candida-in-healthcare-settings_19-Dec-2016.pdf"},{"key":"14_CR26","doi-asserted-by":"publisher","first-page":"E218","DOI":"10.1111\/1469-0691.12111","volume":"19","author":"J Ericsson","year":"2013","unstructured":"Ericsson J, Chryssanthou E, Klingspor L, Johansson AG, Ljungman P, Svensson E, Sj\u00f6lin J (2013) Candidaemia in Sweden: a nationwide prospective observational survey. Clin Microbiol Infect 19:E218\u2013E221","journal-title":"Clin Microbiol Infect"},{"key":"14_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.15585\/mmwr.mm6715a6","volume":"67","author":"P Escand\u00f3n","year":"2018","unstructured":"Escand\u00f3n P, C\u00e1ceres DH, Espinosa-Bode A, Rivera S, Armstrong P, Vallabhaneni S, Berkow EL, Lockhart SR, Chiller T, Jackson BR, Duarte C (2018) Notes from the field: surveillance for Candida auris - Colombia, September 2016-May 2017. MMWR Morb Mortal Wkly Rep 67:459\u2013460","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"14_CR28","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1007\/s10096-014-2194-8","volume":"33","author":"I Faria-Ramos","year":"2014","unstructured":"Faria-Ramos I, Neves-Maia J, Ricardo E, Santos-Antunes J, Silva AT, Costa-de-Oliveira S, Cant\u00f3n E, Rodrigues AG, Pina-Vaz C (2014) Species distribution and in vitro antifungal susceptibility profiles of yeast isolates from invasive infections during a Portuguese multicenter survey. Eur J Clin Microbiol Infect Dis 33:2241\u20132247 Erratum in: (2015) Eur J Clin Microbiol Infect Dis 34:2137","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"14_CR29","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1099\/jmm.0.048785-0","volume":"62","author":"JQ Farooqi","year":"2013","unstructured":"Farooqi JQ, Jabeen K, Saeed N, Iqbal N, Malik B, Lockhart SR, Zafar A, Brandt ME, Hasan R (2013) Invasive candidiasis in Pakistan: clinical characteristics, species distribution and antifungal susceptibility. J Med Microbiol 62:259\u2013268","journal-title":"J Med Microbiol"},{"key":"14_CR30","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jinf.2007.10.014","volume":"56","author":"GN Forrest","year":"2008","unstructured":"Forrest GN, Weekes E, Johnson JK (2008) Increasing incidence of Candida parapsilosis candidemia with caspofungin usage. J Infect 56:126\u2013129","journal-title":"J Infect"},{"key":"14_CR31","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.1093\/jac\/dku225","volume":"69","author":"J Fort\u00fan","year":"2014","unstructured":"Fort\u00fan J, Meije Y, Buitrago MJ, Gago S, Bernal-Martinez L, Pem\u00e1n J, P\u00e9rez M, G\u00f3mez G, Pedrosa E, Madrid N, Pintado V, Mart\u00edn-D\u00e1vila P, Cobo J, Fresco G, Moreno S, Cuenca-Estrella M (2014) Clinical validation of a multiplex real-time PCR assay for detection of invasive candidiasis in intensive care unit patients. J Antimicrob Chemother 69:3134\u20133141","journal-title":"J Antimicrob Chemother"},{"key":"14_CR32","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1186\/s12879-017-2846-2","volume":"17","author":"MF Gonz\u00e1lez-Lara","year":"2017","unstructured":"Gonz\u00e1lez-Lara MF, Torres-Gonz\u00e1lez P, Cornejo-Ju\u00e1rez P, Vel\u00e1zquez-Acosta C, Martinez-Gamboa A, Rangel-Cordero A, Bobadilla-Del-Valle M, Ostrosky-Zeichner L, Ponce-de-Le\u00f3n A, Sifuentes-Osornio J (2017) Impact of inappropriate antifungal therapy according to current susceptibility breakpoints on Candida bloodstream infection mortality, a retrospective analysis. BMC Infect Dis 17:753","journal-title":"BMC Infect Dis"},{"key":"14_CR33","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1093\/jac\/dkr511","volume":"67","author":"SA Grim","year":"2012","unstructured":"Grim SA, Berger K, Teng C, Gupta S, Layden JE, Janda WM, Clark NM (2012) Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes. J Antimicrob Chemother 67:707\u2013714","journal-title":"J Antimicrob Chemother"},{"key":"14_CR34","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1002\/cncr.23466","volume":"112","author":"R Hachem","year":"2008","unstructured":"Hachem R, Hanna H, Kontoyiannis D, Jiang Y, Raad I (2008) The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy. Cancer 112:2493\u20132499","journal-title":"Cancer"},{"key":"14_CR35","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1128\/JCM.42.4.1519-1527.2004","volume":"42","author":"RA Hajjeh","year":"2004","unstructured":"Hajjeh RA, Sofair AN, Harrison LH, Lyon GM, Arthington-Skaggs BA, Mirza SA, Phelan M, Morgan J, Lee-Yang W, Ciblak MA, Benjamin LE, Sanza LT, Huie S, Yeo SF, Brandt ME, Warnock DW (2004) Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol 42:1519\u20131527","journal-title":"J Clin Microbiol"},{"key":"14_CR36","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.cmi.2015.06.008","volume":"21","author":"L Hesstvedt","year":"2015","unstructured":"Hesstvedt L, Gaustad P, Andersen CT, Haarr E, Hannula R, Haukland HH, Hermansen NO, Larssen KW, Mylvaganam H, Ranheim TE, Sandven P, Nord\u00f8y I, Norwegian Yeast Study Group, Kanestr\u00f8m A, Grub C, Onken A, Thielsen C, Skaare D, Tofteland S, S\u00f8nsteby LJ, Hjetland R, Hide R, Vik E, K\u00fcmmel A, \u00c5sheim S (2015) Twenty-two years of candidaemia surveillance: results from a Norwegian national study. Clin Microbiol Infect 21:938\u2013945","journal-title":"Clin Microbiol Infect"},{"key":"14_CR37","doi-asserted-by":"publisher","first-page":"e621","DOI":"10.1016\/j.ijid.2013.02.010","volume":"17","author":"A Kreusch","year":"2013","unstructured":"Kreusch A, Karstaedt AS (2013) Candidemia among adults in Soweto, South Africa, 1990-2007. Int J Infect Dis 17:e621\u2013e623","journal-title":"Int J Infect Dis"},{"key":"14_CR38","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ijantimicag.2012.05.024","volume":"40","author":"CC Lai","year":"2012","unstructured":"Lai CC, Chu CC, Wang CY, Tsai HY, Cheng A, Lee YC, Huang YT, Liao CH, Hsueh PR (2012) Association between incidence of candidaemia and consumption of antifungal agents at a medical centre in Taiwan. Int J Antimicrob Agents 40:349\u2013353","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl. 1","key":"14_CR39","doi-asserted-by":"publisher","first-page":"i4","DOI":"10.1093\/jac\/dkx444","volume":"73","author":"F Lamoth","year":"2018","unstructured":"Lamoth F, Lockhart SR, Berkow EL, Calandra T (2018) Changes in the epidemiological landscape of invasive candidiasis. J Antimicrob Chemother 73(Suppl. 1):i4\u2013i13","journal-title":"J Antimicrob Chemother"},{"key":"14_CR40","doi-asserted-by":"publisher","first-page":"e02396","DOI":"10.1128\/AAC.02396-16","volume":"61","author":"E Larkin","year":"2017","unstructured":"Larkin E, Hager C, Chandra J, Mukherjee PK, Retuerto M, Salem I, Long L, Isham N, Kovanda L, Borroto-Esoda K, Wring S, Angulo D, Ghannoum M (2017) The emerging Candida auris: characterization of growth phenotype, virulence factors, antifungal activity, and effect of SCY-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation. Antimicrob Agents Chemother 61:e02396\u2013e02316","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR41","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.clinmicnews.2014.08.001","volume":"36","author":"SR Lockhart","year":"2014","unstructured":"Lockhart SR (2014) Current epidemiology of Candida infection. Clin Microbiol Newsl 36:131\u2013136","journal-title":"Clin Microbiol Newsl"},{"key":"14_CR42","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1128\/JCM.02315-08","volume":"47","author":"SR Lockhart","year":"2009","unstructured":"Lockhart SR, Messer SA, Gherna M, Bishop JA, Merz WG, Pfaller MA, Diekema DJ (2009) Identification of Candida nivariensis and Candida bracarensis in a large global collection of Candida glabrata isolates: comparison to the literature. J Clin Microbiol 47:1216\u20131217","journal-title":"J Clin Microbiol"},{"key":"14_CR43","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/cid\/ciw691","volume":"64","author":"SR Lockhart","year":"2017","unstructured":"Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, Colombo AL, Calvo B, Cuomo CA, Desjardins CA, Berkow EL, Castanheira M, Magobo RE, Jabeen K, Asghar RJ, Meis JF, Jackson B, Chiller T, Litvintseva AP (2017) Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis 64:134\u2013140","journal-title":"Clin Infect Dis"},{"key":"14_CR44","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.riam.2012.09.001","volume":"30","author":"LM L\u00f3pez-Soria","year":"2013","unstructured":"L\u00f3pez-Soria LM, Bereciartua E, Santamar\u00eda M, Soria LM, Hern\u00e1ndez-Almaraz JL, Mularoni A, Nieto J, Montejo M (2013) First case report of catheter-related fungemia by Candida nivariensis in the Iberian Peninsula. Rev Iberoam Micol 30:69\u201371","journal-title":"Rev Iberoam Micol"},{"key":"14_CR45","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.riam.2016.04.003","volume":"33","author":"EM Mar\u00edn Mart\u00ednez","year":"2016","unstructured":"Mar\u00edn Mart\u00ednez EM, Aller Garc\u00eda AI, Mart\u00edn-Mazuelos E (2016) Epidemiolog\u00eda, factores de riesgo y sensibilidad in vitro en candidemias por especies diferentes de Candida albicans. Rev Iberoam Micol 33:248\u2013252","journal-title":"Rev Iberoam Micol"},{"key":"14_CR46","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1128\/AAC.04922-14","volume":"59","author":"M Mart\u00ed-Carrizosa","year":"2015","unstructured":"Mart\u00ed-Carrizosa M, S\u00e1nchez-Reus F, March F, Cant\u00f3n E, Coll P (2015) Implication of Candida parapsilosis FKS1 and FKS2 mutations in reduced echinocandin susceptibility. Antimicrob Agents Chemother 59:3570\u20133573","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR47","doi-asserted-by":"publisher","first-page":"i5978","DOI":"10.1136\/bmj.i5978","volume":"355","author":"M McCarthy","year":"2016","unstructured":"McCarthy M (2016) Hospital transmitted Candida auris infections confirmed in the US. Br Med J 355:i5978","journal-title":"Br Med J"},{"key":"14_CR48","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1093\/jac\/dkr298","volume":"66","author":"I Miranda-Zapico","year":"2011","unstructured":"Miranda-Zapico I, Eraso E, Hern\u00e1ndez-Almaraz JL, L\u00f3pez-Soria LM, Carrillo-Mu\u00f1oz AJ, Hern\u00e1ndez-Molina JM, Quind\u00f3s G (2011) Prevalence and antifungal susceptibility patterns of new cryptic species inside the species-complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital. J Antimicrob Chemother 66:2315\u20132322","journal-title":"J Antimicrob Chemother"},{"key":"14_CR49","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1128\/JCM.02202-16","volume":"55","author":"M Mizusawa","year":"2017","unstructured":"Mizusawa M, Miller H, Green R, Lee R, Durante M, Perkins R, Hewitt C, Simner PJ, Carroll KC, Hayden RT, Zhang SX (2017) Can multidrug-resistant Candida auris be reliably identified in clinical microbiology laboratories? J Clin Microbiol 55:638\u2013640","journal-title":"J Clin Microbiol"},{"key":"14_CR50","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3201\/eid2301.161497","volume":"23","author":"SE Morales-L\u00f3pez","year":"2017","unstructured":"Morales-L\u00f3pez SE, Parra-Giraldo CM, Ceballos-Garz\u00f3n A, Mart\u00ednez HP, Rodr\u00edguez GJ, \u00c1lvarez-Moreno CA, Rodr\u00edguez JY (2017) Invasive infections with multidrug-resistant yeast Candida auris, Colombia. Emerg Infect Dis 23:162\u2013164","journal-title":"Emerg Infect Dis"},{"key":"14_CR51","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/INF.0b013e3181920ffd","volume":"28","author":"C Moran","year":"2009","unstructured":"Moran C, Grussemeyer CA, Spalding JR, Benjamin DK Jr, Reed SD (2009) Candida albicans and non-albicans bloodstream infections in adult and pediatric patients: comparison of mortality and costs. Pediatr Infect Dis J 28:433\u2013435","journal-title":"Pediatr Infect Dis J"},{"key":"14_CR52","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ajic.2009.06.014","volume":"38","author":"C Moran","year":"2010","unstructured":"Moran C, Grussemeyer CA, Spalding JR, Benjamin DK Jr, Reed SD (2010) Comparison of costs, length of stay, and mortality associated with Candida glabrata and Candida albicans bloodstream infections. Am J Infect Control 38:78\u201380","journal-title":"Am J Infect Control"},{"key":"14_CR53","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jiac.2014.05.009","volume":"20","author":"D Morii","year":"2014","unstructured":"Morii D, Seki M, Binongo JN, Ban R, Kobayashi A, Sata M, Hashimoto S, Shimizu J, Morita S, Tomono K (2014) Distribution of Candida species isolated from blood cultures in hospitals in Osaka, Japan. J Infect Chemother 20:558\u2013562","journal-title":"J Infect Chemother"},{"key":"14_CR54","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1111\/j.1469-0691.2010.03338.x","volume":"17","author":"P Mu\u00f1oz","year":"2011","unstructured":"Mu\u00f1oz P, Giannella M, Fanciulli C, Guinea J, Valerio M, Rojas L, Rodr\u00edguez-Cr\u00e9ixems M, Bouza E (2011) Candida tropicalis fungaemia: incidence, risk factors and mortality in a general hospital. Clin Microbiol Infect 17:1538\u20131545","journal-title":"Clin Microbiol Infect"},{"key":"14_CR55","doi-asserted-by":"publisher","first-page":"e59373","DOI":"10.1371\/journal.pone.0059373","volume":"8","author":"M Nucci","year":"2013","unstructured":"Nucci M, Queiroz-Telles F, Alvarado-Matute T, Tiraboschi IN, Cortes J, Zurita J, Guzman-Blanco M, Santolaya ME, Thompson L, Sifuentes-Osornio J, Echevarria JI, Colombo AL, Latin American Invasive Mycosis Network (2013) Epidemiology of candidemia in Latin America: a laboratory-based survey. PLoS One 8:e59373","journal-title":"PLoS One"},{"key":"14_CR56","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.riam.2011.02.005","volume":"28","author":"J Pem\u00e1n","year":"2011","unstructured":"Pem\u00e1n J, Cant\u00f3n E, Mi\u00f1ana JJ, Florez JA, Echeverria J, Ortega DN, Alarc\u00f3n JM, Fontanals D, Sard BG, Moreno BB, Torroba L, Ayats J, P\u00e9rez M\u00c1, Fern\u00e1ndez MA, Reus FS, Natal IF, Garc\u00eda GR, Ezpeleta G, Mart\u00edn-Mazuelos E, Iglesias I, Rezusta A, de Ocariz IR, Nieto AG, el Grupo de Estudio FUNGEMYCA (2011) Changes in the epidemiology of fungaemia and fluconazole susceptibility of blood isolates during the last 10 years in Spain: results from the FUNGEMYCA study. Rev Iberoam Micol 28:91\u201399","journal-title":"Rev Iberoam Micol"},{"key":"14_CR57","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1093\/jac\/dks019","volume":"67","author":"J Pem\u00e1n","year":"2012","unstructured":"Pem\u00e1n J, Cant\u00f3n E, Quind\u00f3s G, Eraso E, Alcoba-Fl\u00f3rez J, Guinea J, Merino P, Ruiz-P\u00e9rez-de-Pipaon MT, P\u00e9rez-del-Molino L, Linares-Sicilia MJ, Marco F, Garc\u00eda J, Rosell\u00f3 EM, G\u00f3mez-G-de-la-Pedrosa E, Borrell N, Porras A, Yag\u00fce G, FUNGEMYCA Study Group (2012) Epidemiology, species distribution, and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey. J Antimicrob Chemother 67:1181\u20131187","journal-title":"J Antimicrob Chemother"},{"key":"14_CR58","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1016\/S1473-3099(17)30316-X","volume":"17","author":"DS Perlin","year":"2017","unstructured":"Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A (2017) The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis 17:e383\u2013e392","journal-title":"Lancet Infect Dis"},{"key":"14_CR59","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/1471-2334-10-312","volume":"10","author":"E Poikonen","year":"2010","unstructured":"Poikonen E, Lyytik\u00e4inen O, Anttila VJ, Koivula I, Lumio J, Kotilainen P, Syrj\u00e4l\u00e4 H, Ruutu P (2010) Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007. BMC Infect Dis 10:312","journal-title":"BMC Infect Dis"},{"key":"14_CR60","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s15010-016-0951-6","volume":"44","author":"A Prigitano","year":"2016","unstructured":"Prigitano A, Cavanna C, Passera M, Ossi C, Sala E, Lombardi G, Grancini A, De Luca C, Bramati S, Gelmi M, Tejada M, Grande R, Farina C, Lallitto F, Tortorano AM (2016) CAND-LO 2014-15 study: changing epidemiology of candidemia in Lombardy (Italy). Infection 44:765\u2013780","journal-title":"Infection"},{"key":"14_CR61","doi-asserted-by":"publisher","first-page":"O245","DOI":"10.1111\/1469-0691.12380","volume":"20","author":"M Puig-Asensio","year":"2014","unstructured":"Puig-Asensio M, Padilla B, Garnacho-Montero J, Zaragoza O, Aguado JM, Zaragoza R, Montejo M, Mu\u00f1oz P, Ruiz-Camps I, Cuenca-Estrella M, Almirante B, CANDIPOP Project; GEIH-GEMICOMED (SEIMC); REIPI (2014) Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain. Clin Microbiol Infect 20:O245\u2013O254","journal-title":"Clin Microbiol Infect"},{"key":"14_CR62","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.riam.2013.10.001","volume":"31","author":"G Quind\u00f3s","year":"2014","unstructured":"Quind\u00f3s G (2014) Epidemiology of candidaemia and invasive candidiasis. A changing face. Rev Iberoam Micol 31:42\u201348","journal-title":"Rev Iberoam Micol"},{"key":"14_CR63","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ijantimicag.2007.09.010","volume":"31","author":"G Quind\u00f3s","year":"2008","unstructured":"Quind\u00f3s G, S\u00e1nchez-Vargas LO, Villar-Vidal M, Eraso E, Alkorta M, Hern\u00e1ndez-Almaraz JL (2008) Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre. Int J Antimicrob Agents 31:266\u2013271","journal-title":"Int J Antimicrob Agents"},{"key":"14_CR64","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.eimc.2011.10.018","volume":"30","author":"G Quind\u00f3s","year":"2012","unstructured":"Quind\u00f3s G, Eraso E, L\u00f3pez-Soria LM, Ezpeleta G (2012) Enfermedad f\u00fangica invasora: \u00bfDiagn\u00f3stico micol\u00f3gico convencional o molecular? Enferm Infecc Microbiol Clin 30:560\u2013571","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"14_CR65","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3389\/fmicb.2016.00915","volume":"7","author":"R Rajendran","year":"2016","unstructured":"Rajendran R, Sherry L, Deshpande A, Johnson EM, Hanson MF, Williams C, Munro CA, Jones BL, Ramage G (2016) A prospective surveillance study of candidaemia: epidemiology, risk factors, antifungal treatment and outcome in hospitalized patients. Front Microbiol 7:915","journal-title":"Front Microbiol"},{"key":"14_CR66","doi-asserted-by":"publisher","first-page":"e0175172","DOI":"10.1371\/journal.pone.0175172","volume":"12","author":"L Rodr\u00edguez","year":"2017","unstructured":"Rodr\u00edguez L, Bustamante B, Huaroto L, Agurto C, Illescas R, Ramirez R, Diaz A, Hidalgo J (2017) A multi-centric study of Candida bloodstream infection in Lima-Callao, Peru: species distribution, antifungal resistance and clinical outcomes. PLoS One 12:e0175172","journal-title":"PLoS One"},{"key":"14_CR67","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1093\/jac\/dkx034","volume":"72","author":"SM Rudramurthy","year":"2017","unstructured":"Rudramurthy SM, Chakrabarti A, Paul RA, Sood P, Kaur H, Capoor MR, Kindo AJ, Marak RSK, Arora A, Sardana R, Das S, Chhina D, Patel A, Xess I, Tarai B, Singh P, Ghosh A (2017) Candida auris candidaemia in Indian ICUs: analysis of risk factors. J Antimicrob Chemother 72:1794\u20131801","journal-title":"J Antimicrob Chemother"},{"key":"14_CR68","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.riam.2016.11.002","volume":"34","author":"AC Ruiz Gait\u00e1n","year":"2017","unstructured":"Ruiz Gait\u00e1n AC, Moret A, L\u00f3pez Hontangas JL, Molina JM, Aleixandre L\u00f3pez AI, Cabezas AH, Mollar Maseres J, Arcas RC, G\u00f3mez Ruiz MD, Chiveli M\u00c1, Cant\u00f3n E, Pem\u00e1n J (2017) Nosocomial fungemia by Candida auris: first four reported cases in continental Europe. Rev Iberoam Micol 34:23\u201327","journal-title":"Rev Iberoam Micol"},{"key":"14_CR69","doi-asserted-by":"crossref","unstructured":"Ruiz-Gait\u00e1n A, Moret AM, Tasias-Pitarch M, Aleixandre-Lopez AI, Mart\u00ednez-Morel H, Calabuig E, Salavert-Llet\u00ed M, Ram\u00edrez P, L\u00f3pez-Hontangas JL, Hagen F, Meis JF, Mollar-Maseres J, Pem\u00e1n J (2018) An outbreak due to Candida auris with prolonged colonization and candidemia in a tertiary care European hospital. Mycoses 61:498\u2013505","DOI":"10.1111\/myc.12781"},{"key":"14_CR70","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s10096-017-2930-y","volume":"36","author":"R Sabino","year":"2017","unstructured":"Sabino R, Veriss\u00edmo C, Brand\u00e3o J, Martins C, Alves D, Pais C, Denning DW (2017) Serious fungal infections in Portugal. Eur J Clin Microbiol Infect Dis 36:1345\u20131352","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"14_CR71","doi-asserted-by":"crossref","unstructured":"Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H (2009) Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol 53:41\u201344","DOI":"10.1111\/j.1348-0421.2008.00083.x"},{"key":"14_CR72","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13756-016-0132-5","volume":"5","author":"S Schelenz","year":"2016","unstructured":"Schelenz S, Hagen F, Rhodes JL, Abdolrasouli A, Chowdhary A, Hall A, Ryan L, Shackleton J, Trimlett R, Meis JF, Armstrong-James D, Fisher MC (2016) First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control 5:35","journal-title":"Antimicrob Resist Infect Control"},{"key":"14_CR73","first-page":"w14281","volume":"146","author":"Y Schmiedel","year":"2016","unstructured":"Schmiedel Y, Zimmerli S (2016) Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia. Swiss Med Wkly 146:w14281","journal-title":"Swiss Med Wkly"},{"key":"14_CR74","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3201\/eid2302.161320","volume":"23","author":"L Sherry","year":"2017","unstructured":"Sherry L, Ramage G, Kean R, Borman A, Johnson EM, Richardson MD, Rautemaa-Richardson R (2017) Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris. Emerg Infect Dis 23:328\u2013331","journal-title":"Emerg Infect Dis"},{"key":"14_CR75","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1155\/2008\/634046","volume":"19","author":"G St-Germain","year":"2008","unstructured":"St-Germain G, Laverdi\u00e8re M, Pelletier R, Ren\u00e9 P, Bourgault AM, Lemieux C, Libman M (2008) Epidemiology and antifungal susceptibility of bloodstream Candida isolates in Quebec: report on 453 cases between 2003 and 2005. Can J Infect Dis Med Microbiol 19:55\u201362","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"14_CR76","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.cmi.2015.06.010","volume":"21","author":"BH Tan","year":"2015","unstructured":"Tan BH, Chakrabarti A, Li RY, Patel AK, Watcharananan SP, Liu Z, Chindamporn A, Tan AL, Sun PL, Wu UI, Chen YC, Asia Fungal Working Group (AFWG) (2015) Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study. Clin Microbiol Infect 21:946\u2013953","journal-title":"Clin Microbiol Infect"},{"key":"14_CR77","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.ijantimicag.2006.01.002","volume":"27","author":"AM Tortorano","year":"2006","unstructured":"Tortorano AM, Kibbler C, Peman J, Bernhardt H, Klingspor L, Grillot R (2006) Candidaemia in Europe: epidemiology and resistance. Int J Antimicrob Agents 27:359\u2013366","journal-title":"Int J Antimicrob Agents"},{"key":"14_CR78","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s10096-016-2841-3","volume":"36","author":"C Trouv\u00e9","year":"2017","unstructured":"Trouv\u00e9 C, Blot S, Hayette MP, Jonckheere S, Patteet S, Rodriguez-Villalobos H, Symoens F, Van Wijngaerden E, Lagrou K (2017) Epidemiology and reporting of candidaemia in Belgium: a multi-centre study. Eur J Clin Microbiol Infect Dis 36:649\u2013655","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"14_CR79","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.15585\/mmwr.mm6544e1","volume":"65","author":"S Vallabhaneni","year":"2016","unstructured":"Vallabhaneni S, Kallen A, Tsay S, Chow N, Welsh R, Kerins J, Kemble SK, Pacilli M, Black SR, Landon E, Ridgway J, Palmore TN, Zelzany A, Adams EH, Quinn M, Chaturvedi S, Greenko J, Fernandez R, Southwick K, Furuya EY, Calfee DP, Hamula C, Patel G, Barrett P, Lafaro P, Berkow EL, Moulton-Meissner H, Noble-Wang J, Fagan RP, Jackson BR, Lockhart SR, Litvintseva AP, Chiller TM (2016) Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus\u2014United States, May 2013\u2013August 2016. MMWR Morb Mortal Wkly Rep 65:1234\u20131237","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"14_CR80","doi-asserted-by":"publisher","first-page":"e0185339","DOI":"10.1371\/journal.pone.0185339","volume":"12","author":"A Vena","year":"2017","unstructured":"Vena A, Bouza E, Valerio M, Padilla B, Pa\u00f1o-Pardo JR, Fern\u00e1ndez-Ruiz M, D\u00edaz Mart\u00edn A, Salavert M, Mularoni A, Puig-Asensio M, Mu\u00f1oz P, CANDIPOP Project (2017) Candidemia in non-ICU surgical wards: comparison with medical wards. PLoS One 12:e0185339","journal-title":"PLoS One"},{"key":"14_CR81","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3201\/eid0702.010203","volume":"7","author":"RP Wenzel","year":"2001","unstructured":"Wenzel RP, Edmond MB (2001) The impact of hospital-acquired bloodstream infections. Emerg Infect Dis 7:174\u2013177","journal-title":"Emerg Infect Dis"},{"issue":"Suppl. 6","key":"14_CR82","doi-asserted-by":"publisher","first-page":"S389","DOI":"10.1086\/430923","volume":"41","author":"RP Wenzel","year":"2005","unstructured":"Wenzel RP, Gennings C (2005) Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies. Clin Infect Dis 41(Suppl. 6):S389\u2013S393 Erratum in: (2005) Clin Infect Dis 41 (Suppl. 6):1694","journal-title":"Clin Infect Dis"},{"key":"14_CR83","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/INF.0000000000000009","volume":"33","author":"H Xia","year":"2014","unstructured":"Xia H, Wu H, Xia S, Zhu X, Chen C, Qiu G, Zhou W, Shi Y, Ma L, Sun J, Zhou X, Zhu J (2014) Invasive candidiasis in preterm neonates in China: a retrospective study from 11 NICUS during 2009-2011. Pediatr Infect Dis J 33:106\u2013109","journal-title":"Pediatr Infect Dis J"},{"key":"14_CR84","doi-asserted-by":"publisher","first-page":"e7830","DOI":"10.1097\/MD.0000000000007830","volume":"96","author":"Y Yang","year":"2017","unstructured":"Yang Y, Guo F, Kang Y, Zang B, Cui W, Qin B, Qin Y, Fang Q, Qin T, Jiang D, Cai B, Li R, Qiu H, China-SCAN Team (2017) Epidemiology, clinical characteristics, and risk factors for mortality of early- and late-onset invasive candidiasis in intensive care units in China. Medicine (Baltimore) 96:e7830","journal-title":"Medicine (Baltimore)"}],"container-title":["International Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10123-018-0014-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10123-018-0014-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10123-018-0014-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T19:03:31Z","timestamp":1562353411000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10123-018-0014-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,6]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["14"],"URL":"https:\/\/doi.org\/10.1007\/s10123-018-0014-1","relation":{},"ISSN":["1139-6709","1618-1905"],"issn-type":[{"value":"1139-6709","type":"print"},{"value":"1618-1905","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,6]]},"assertion":[{"value":"27 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"We have no specific conflicts of interest related to the current manuscript but declare the following: GQ has received research grants from Astellas Pharma, Pfizer, Merck Sharp & Dohme, and Scynexis. GQ has served on advisory\/consultant boards for Merck, Sharp & Dohme, and Scynexis, and he has received speaker honoraria from Abbvie, Astellas Pharma, Merck Sharp & Dohme, Pfizer, and Scynexis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}